In 1996, Brazil was the first country in the world to provide full and free access to antiretrovirals as part of a broad prevention and treatment health program. This decision was challenged by powerful pharmaceutical companies and even by the US government. The government of Brazil launched an international campaign to promote access to these medicines as a global public good and basic human right. In 2001, international health agencies, like the World Health Organizaiton, adopted the Brazilian model but were unable to implement it in other developing countries. This presentation will discuss the meanings and vicissitudes of universal access to antiretrovirals in global health at the turn of the 21st century.
Marcos Cueto, Fiocruz, Rio de Janeiro
Cueto is a professor at the Casa de Oswaldo Cruz, a unit of the Brazilian Fundação Oswaldo Cruz (Fiocruz), where he teaches the history of health in Latin America and is editor of the journal Histórisa Ciência Saúe Manguinhos. He has published several books and articles on the history of health and medicine in Latin America, especially during the 20th century. His most recent book Medicine and Public Health in Latin America: A History (Cambridge University Press, 2014) -- co authored with Steven Palmer -- received in 2017 the George Rosen Prize of the American Association of the History of Medicine. During the Spring of 2018, he will be the Robert F. Kennedy Visiting Professor of the David Rockefeller Center for Latin American Studies, Harvard University.